506414 — Fermenta Biotech Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual income statement for Fermenta Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,773	3,985	3,499	3,357	4,695
Cost of Revenue
Gross Profit	2,200	2,133	1,683	1,733	3,221
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,147	3,626	3,880	3,400	3,839
Operating Profit	626	359	-381	-43.1	856
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	516	269	-519	-98.7	832
Provision for Income Taxes
Net Income After Taxes	425	151	-536	-240	764
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	455	154	-515	-231	769
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	455	154	-515	-231	769
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	15.7	5.33	-11.4	-6.24	26.4
Dividends per Share